Empagliflozin for the Treatment of Postprandial Hypoglycemia
Clinical trial NCT05036317 · TERMINATED
Trial details
- NCT number
- NCT05036317
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-11
- Primary completion
- 2024-08-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.